HS
IRON icon

HighVista Strategies’s Disc Medicine IRON Stock Holding History

HighVista Strategies’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,733
Closed -$357K – 163
2025
Q2 		$357K Buy
6,733
+275
+4% +$12.9K 0.13% 136
2025
Q1 		$321K Hold
6,458
– – 0.12% 137
2024
Q4 		$409K Sell
6,458
-3,107
-32% -$180K 0.15% 127
2024
Q3 		$470K Buy
+9,565
New +$449K 0.16% 132

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighVista Strategies's IRON Position: Q3 2025 in Review

HighVista Strategies sold out of Disc Medicine (IRON) in Q3 2025, closing a stake of 6,733 shares — an estimated $357K sold.

HighVista Strategies first reported a position in IRON in Q3 2024 and held it in 4 quarters. The position peaked at $470K in Q3 2024. 168 funds tracked by Wall St. Rank hold IRON as of Q3 2025.

  • HighVista Strategies reported no remaining Disc Medicine position as of Q3 2025 after selling out during the quarter.
  • HighVista Strategies sold 6,733 Disc Medicine shares in Q3 2025, an estimated $357K.
  • HighVista Strategies first reported a position in Disc Medicine in Q3 2024 and held it in 4 quarters.
  • HighVista Strategies's Disc Medicine position peaked at $470K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2025.

Based on HighVista Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.